These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1429103)

  • 1. The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms.
    Thornton AF; Sandler HM; Ten Haken RK; McShan DL; Fraass BA; La Vigne ML; Yanke BR
    Int J Radiat Oncol Biol Phys; 1992; 24(4):767-75. PubMed ID: 1429103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative assessment of the addition of MRI to CT-based, 3-D treatment planning of brain tumors.
    Ten Haken RK; Thornton AF; Sandler HM; LaVigne ML; Quint DJ; Fraass BA; Kessler ML; McShan DL
    Radiother Oncol; 1992 Oct; 25(2):121-33. PubMed ID: 1332134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas.
    Grosu AL; Weber W; Feldmann HJ; Wuttke B; Bartenstein P; Gross MW; Lumenta C; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):517-26. PubMed ID: 10802381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain tumor delineation based on CT and MR imaging. Implications for radiotherapy treatment planning.
    Heesters MA; Wijrdeman HK; Struikmans H; Witkamp T; Moerland MA
    Strahlenther Onkol; 1993 Dec; 169(12):729-33. PubMed ID: 8284745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of treatment volumes from CT and MRI in high-grade gliomas: implications for radiotherapy.
    Myrianthopoulos LC; Vijayakumar S; Spelbring DR; Krishnasamy S; Blum S; Chen GT
    Magn Reson Imaging; 1992; 10(3):375-83. PubMed ID: 1328802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomography-magnetic resonance image fusion: a clinical evaluation of an innovative approach for improved tumor localization in primary central nervous system lesions.
    Lattanzi JP; Fein DA; McNeeley SW; Shaer AH; Movsas B; Hanks GE
    Radiat Oncol Investig; 1997; 5(4):195-205. PubMed ID: 9327499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
    Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
    Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of magnetic resonance imaging in target volume delineation of base of tongue tumours--a study using flexible surface coils.
    Ahmed M; Schmidt M; Sohaib A; Kong C; Burke K; Richardson C; Usher M; Brennan S; Riddell A; Davies M; Newbold K; Harrington KJ; Nutting CM
    Radiother Oncol; 2010 Feb; 94(2):161-7. PubMed ID: 20096947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
    Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
    Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas.
    Gross MW; Weber WA; Feldmann HJ; Bartenstein P; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):989-95. PubMed ID: 9719107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
    Pirzkall A; Li X; Oh J; Chang S; Berger MS; Larson DA; Verhey LJ; Dillon WP; Nelson SJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):126-37. PubMed ID: 15093908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
    Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric characterization of MRI-only treatment planning for brain tumors in atlas-based pseudo-CT images generated from standard T1-weighted MR images.
    Demol B; Boydev C; Korhonen J; Reynaert N
    Med Phys; 2016 Dec; 43(12):6557. PubMed ID: 27908187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Delay Between Gadolinium Chelate Administration and T1-Weighted Magnetic Resonance Imaging Acquisition Increases Contrast-Enhancing Tumor Volumes and T1 Intensities in Brain Tumor Patients.
    Piechotta PL; Bonekamp D; Sill M; Wick A; Wick W; Bendszus M; Kickingereder P
    Invest Radiol; 2018 Apr; 53(4):223-228. PubMed ID: 29200014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
    Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
    Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.
    Kelly PJ; Daumas-Duport C; Kispert DB; Kall BA; Scheithauer BW; Illig JJ
    J Neurosurg; 1987 Jun; 66(6):865-74. PubMed ID: 3033172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fiducial marker for prostate radiotherapy: comparison of 0.35- and 0.5-mm-diameter computed tomography and magnetic resonance images.
    Tanaka O; Komeda H; Iida T; Tamaki M; Seike K; Kato D; Hirose S; Kawaguchi D; Yokoyama T
    Radiol Med; 2017 Mar; 122(3):204-207. PubMed ID: 27981486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine meningiomas treated with three-dimensional conformal radiation therapy require magnetic resonance imaging to avoid a geographic miss.
    Berlato D; Zwingenberger AL; Ruiz-Drebing M; Pradel J; Clark N; Kent MS
    Vet Radiol Ultrasound; 2018 Nov; 59(6):777-785. PubMed ID: 29956402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of MRI scan protocols for use in 3-D, CT-based treatment planning.
    Yanke BR; Ten Haken RK; Aisen A; Fraass BA; Thornton AF
    Med Dosim; 1991 Dec; 16(4):205-11. PubMed ID: 1764171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.